A new Covid variant called Omicron has the world worried. How serious is it, and how should we think about it as investors? Meanwhile Nanosonics has been a strong performer over recent years - but what's the investment case today? Andrew, Kev, Matt, and Claude dig in.
A new Covid variant called Omicron has the world worried. How serious is it, and how should we think about it as investors? Meanwhile Nanosonics has been a strong performer over recent years - but what's the investment case today? Andrew, Kev, Matt, and Claude dig in.